Peter H. O'Donnell to Tumor Burden
This is a "connection" page, showing publications Peter H. O'Donnell has written about Tumor Burden.
Connection Strength
0.154
-
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108. Cancer. 2020 01 15; 126(2):432-443.
Score: 0.154